U.S. market Closed. Opens in 20 hours 32 minutes

CALA | Calithera Biosciences, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2022-12-312021-12-312020-12-312019-12-312018-12-31
RevenueN/A9.75MN/AN/A22.25M
Cost of Revenue1.39M1.43M1.87M1.84MN/A
Gross Profit-1.39M8.32M-1.87M-1.84M22.25M
Operating Expenses40.69M74.31M91.39M92.89M79.53M
Selling, General & Admin12.16M20.85M20.37M16.61M13.34M
Research & Development28.53M53.45M71.02M76.29M66.19M
Other Operating ExpensesN/A50.88MN/AN/AN/A
Operating Income-42.07M-115.43M-91.39M-92.89M-57.28M
Other Expenses / Income2.42M345.00K1.25M3.04M2.65M
Before Tax Income-39.65M-115.09M-90.14M-89.86M-54.63M
Income Tax Expenses-20.78M50.25M-1.61M-3.51M-3.16M
Net Income-18.87M-165.34M-88.52M-86.35M-51.47M
Interest ExpensesN/AN/AN/AN/AN/A
Basic Shares Outstanding4.99M3.69M3.44M2.37M1.83M
Diluted Shares Outstanding4.99M3.69M3.44M2.37M1.83M
EBITDA-38.27M-115.43M-88.27M-88.02M-57.28M
EBITDA Margin0.00%-1,183.93%0.00%0.00%-257.40%
EBIT-39.65M-115.09M-90.14M-89.86M-54.63M
EBIT Margin0.00%-1,180.39%0.00%0.00%-245.48%
Financial Year End2022-12-312021-12-312020-12-312019-12-312018-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙